Granahan Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.57M | Buy |
913,622
+437,676
| +92% | +$4.11M | 0.35% | 72 |
|
2025
Q1 | $3.38M | Buy |
475,946
+169,436
| +55% | +$1.2M | 0.17% | 115 |
|
2024
Q4 | $3.57M | Buy |
306,510
+22,976
| +8% | +$268K | 0.15% | 127 |
|
2024
Q3 | $5.83M | Buy |
283,534
+68,624
| +32% | +$1.41M | 0.23% | 115 |
|
2024
Q2 | $4.81M | Sell |
214,910
-5,309
| -2% | -$119K | 0.19% | 127 |
|
2024
Q1 | $6.06M | Sell |
220,219
-37,572
| -15% | -$1.03M | 0.21% | 117 |
|
2023
Q4 | $7.86M | Buy |
257,791
+52,600
| +26% | +$1.6M | 0.26% | 100 |
|
2023
Q3 | $6.49M | Sell |
205,191
-56,674
| -22% | -$1.79M | 0.23% | 112 |
|
2023
Q2 | $10.7M | Buy |
261,865
+2,581
| +1% | +$105K | 0.33% | 84 |
|
2023
Q1 | $9.66M | Buy |
259,284
+41,661
| +19% | +$1.55M | 0.29% | 92 |
|
2022
Q4 | $7.59M | Buy |
217,623
+66,788
| +44% | +$2.33M | 0.23% | 107 |
|
2022
Q3 | $8.44M | Sell |
150,835
-13,510
| -8% | -$756K | 0.28% | 100 |
|
2022
Q2 | $8.51M | Buy |
164,345
+71,736
| +77% | +$3.71M | 0.29% | 90 |
|
2022
Q1 | $6.73M | Sell |
92,609
-23,174
| -20% | -$1.68M | 0.17% | 120 |
|
2021
Q4 | $13.7M | Sell |
115,783
-71,202
| -38% | -$8.42M | 0.28% | 98 |
|
2021
Q3 | $25.1M | Sell |
186,985
-38,818
| -17% | -$5.21M | 0.48% | 48 |
|
2021
Q2 | $36.6M | Buy |
225,803
+16,414
| +8% | +$2.66M | 0.68% | 36 |
|
2021
Q1 | $16.8M | Buy |
209,389
+87,246
| +71% | +$7M | 0.36% | 64 |
|
2020
Q4 | $6.65M | Buy |
122,143
+48,109
| +65% | +$2.62M | 0.15% | 112 |
|
2020
Q3 | $1.47M | Sell |
74,034
-2,271
| -3% | -$45.2K | 0.05% | 164 |
|
2020
Q2 | $1.6M | Buy |
76,305
+16,963
| +29% | +$357K | 0.06% | 159 |
|
2020
Q1 | $726K | Sell |
59,342
-765
| -1% | -$9.36K | 0.04% | 168 |
|
2019
Q4 | $882K | Buy |
60,107
+416
| +0.7% | +$6.1K | 0.04% | 160 |
|
2019
Q3 | $797K | Buy |
59,691
+4,528
| +8% | +$60.5K | 0.04% | 162 |
|
2019
Q2 | $903K | Sell |
55,163
-1,597
| -3% | -$26.1K | 0.04% | 165 |
|
2019
Q1 | $969K | Sell |
56,760
-4,074
| -7% | -$69.6K | 0.05% | 172 |
|
2018
Q4 | $830K | Sell |
60,834
-21,525
| -26% | -$294K | 0.06% | 170 |
|
2018
Q3 | $2.36M | Sell |
82,359
-38,286
| -32% | -$1.1M | 0.13% | 143 |
|
2018
Q2 | $3.3M | Buy |
120,645
+10,203
| +9% | +$279K | 0.2% | 126 |
|
2018
Q1 | $2.33M | Sell |
110,442
-20,166
| -15% | -$425K | 0.17% | 143 |
|
2017
Q4 | $2.51M | Sell |
130,608
-155,536
| -54% | -$2.99M | 0.2% | 132 |
|
2017
Q3 | $7.11M | Buy |
286,144
+18,784
| +7% | +$467K | 0.59% | 61 |
|
2017
Q2 | $4.28M | Buy |
+267,360
| New | +$4.28M | 0.39% | 91 |
|